Radiolabelling methods

Details Radiolabelling methods Radiolabelling methods

2011-07-05

2011-07-05

Jones, D. L (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S001810, C424S001850, C424S001890

Reexamination Certificate

active

07972588

ABSTRACT:
The invention relates to radiodiagnostic and radiotherapeutic agents, including biologically active vectors labelled with radionuclides. It further relates to methods and reagents labelling a vector such as a peptide comprising reaction of a compound of formula (I) with a compound of formula (II): R*-L2-N3(II) or, a compound of formula (III) with a compound of formula (IV) in the presence of a Cu (I) catalyst. The resultant labelled conjugates are useful as diagnostic agents, for example, as radiopharmaceuticals more specifically for use in Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) or for radiotherapy.

REFERENCES:
patent: 4913891 (1990-04-01), Fowler
patent: 2002/0006947 (2002-01-01), Hogenkamp et al.
patent: 03/006491 (2003-01-01), None
patent: 03/101972 (2003-12-01), None
patent: 2004/055160 (2004-07-01), None
patent: 2004/094593 (2004-11-01), None
patent: 2005/003294 (2005-01-01), None
patent: 2006038184 (2006-04-01), None
GB0428012.9 Search report dated Mar. 11, 2005.
PCT/GB2005/004729 Int'l Search Report & Written Opinion dated May 30, 2007.
Haubner, R. et.al., “Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies” Current Pharmaceutical Design, Bentham Sciene Publishers, Schiphol, NL, vol. 10, No. 13, May 2004 pp. 1439-1455.
Kolb, H.C. et.al., “The growing impact of click chemistry on drug discovery” Elsevier Science Ltd., GB vol. 8, No. 24, Dec. 2003, pp. 1128-1137.
Deiters Alexander et al: “Adding amino acids with novel reactivity to the genetic code ofSaccharomyces cerevisiae.” Journal of the American Chemical Society Oct. 1, 2003, vol. 125, No. 39, Oct. 1, 2003, pp. 11782-11783, XP002469881 ISSN: 0002-7873.
Link A James et al: “Cell surface labeling ofEscherichia colivia copper(I)-catalyzed [3+2] cycloaddition.” Journal of the American Chemical Society Sep. 17, 2003, vol. 125, No. 37, Sep. 17, 2003, pp. 11164-11165, XP002469882 ISSN: 0002-7863.
Hashizume Kazunari et al: “Synthesis of Positron Labeled Photoactive Compounds: 18F Labeled Aryl Azides for Positron Labeling of Biochemical Molecules” Journal of Organic Chemistry, American Chemical Society, Easton.; US LNKD-DOI:10.1021/JO00126A015, vol. 60, No. 21, Oct. 1, 1995, pp. 6680-6681.
Vanbrocklin H F et al: “The synthesis of 7alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents” Steroids, Elsevier Science Publishers, New York, NY, LNKD-DOI:10.1016/0039-128X(94)90043-4, vol. 59, No. 1, Jan. 1, 1994, pp. 34-45.
Dolle Frederic et al: “Efficient synthesis and formulation of (R)-(-)-(11C)Deprenyl, a selective radioligand for the quantification of MAO-B activity using Pet” Journal of Labelled Compounds and Radiopharmaaceuticals, vol. 45, No. 10, Sep. 2002, pp. 803-811.
Lange Christopher W et al: “Photoconjugation of 3-azido-5-nitrobenzyl-(18F)fluoride to an oligonucleotide aptamer” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 45, No. 3, Mar. 15, 2002, pp. 257-268.
Guillouet S: “Synthesis of 18F-labelled-4-ethynyl-2-fluorobenzaldehyde, first step of a TpOH inhibitor: 4-Ethynyl-2-(18F)fluoro-pEPA.” Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 46, No. Supplement Aug. 1, 2003, p. S154, XP0081285452 & 15th International Symposium on Radiopharmaceutical Chemistry; Sydney, Australia; Aug. 10-14, 2003.
Blye R P et al: “Development and use of a radioimmunoassay for D-(-)-norgestrel 17beta-cyclopentame-carboxylate” Steroids, Elesvier Science Publishers, New York, NY, US LNKD- DOI:10.1016/0039-128X (86)90039-5, vol. 48, No. 1-2. Jul. 1, 1986, pp. 27-45.
Poethko T et al: “Two-step methodology for high-yield routine radiohalogenation of peptides: 18F-labeled RGD and Octreotide Analogs” Journal of Nuclear Medicine, Society of Nuclear Medicine, Reston, Va, US, vol. 45, No. 5, May 1, 2004, pp. 892-902.

Affiliated with

Also associated with

Rating

Radiolabelling methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabelling methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabelling methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2654702